Episode #1964

Rick Doblin

· 5 books mentioned

Books mentioned

Timestamps are segment start times from the podscripts.co transcript of the audio release (includes ad reads), so they may differ from the video by a few minutes.

Rick Doblin, founder and president of MAPS, discusses the therapeutic potential of psychedelics such as MDMA, LSD, DMT, and ibogaine. The conversation covers MDMA-assisted therapy for PTSD, ibogaine for addiction, drug-policy reform, and the challenges of financing and commercializing psychedelic medicine while preserving public benefit.

What they talked about

  • Founding MAPS and 51 years of psychedelic advocacy
  • Building bridges with political opponents like Ted Nugent
  • MeO-DMT experience and the moment of creation
  • Ibogaine for opiate withdrawal and neuroplasticity
  • MDMA neurotoxicity myths and the retracted primate study
  • Good Friday Experiment and follow-up research
  • Concord Prison Experiment and Timothy Leary's data trick
  • MAPS public benefit corporation and funding model

Episode sources